Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker
- BOND RX™ Validated
- Recombinant
- Lab Essentials
- What is this?
4
(23 Reviews)
|
(430 Publications)
Anti-Myelin Basic Protein antibody [12] (ab7349) is a rat monoclonal antibody detecting Myelin Basic Protein in Western Blot, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- Clone 12 is the most cited clone to Myelin Basic Protein
- Over 310 publications
- Trusted since 2001
View Alternative Names
Myelin basic protein, MBP, Myelin A1 protein, Myelin membrane encephalitogenic protein
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
Immunohistochemical analysis of paraffin-embedded Human cerebrum labeling Myelin Basic Protein with ab7349 at 1/4000 dilution (0.259 μg/ml) followed by a ready to use Goat Anti-Rat IgG H&L (HRP polymer; ab214882). The section was incubated with ab7349 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
Immunohistochemical analysis of paraffin-embedded Human cerebrum labeling Myelin Basic Protein with ab7349 at 1/4000 dilution (0.259 μg/ml) followed by a ready to use Goat Anti-Rat IgG H&L (HRP polymer; ab214882). The section was incubated with ab7349 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with DAPI.
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized mouse primary neural/glia cells labelling Myelin Basic Protein with ab7349 at a 1/200 dilution, followed by Goat anti-Rat (Alexa Fluor® 488) (ab150157) secondary antibody at a 1/1000 dilution. Confocal image showing positive staining in mouse primary oligodendroglia cells (shown in green). Nuclear DNA was labeled with DAPI (shown in blue).
Counterstained with Anti-MAP2 antibody (ab183830) at a 1/1000 dilution, followed by Goat Anti-Rabbit secondary (Alexa Fluor® 594) (ab150080) at a 1/1000 dilution (shown in magenta).
Confocal scanning Z step was set as 0.3 μm followed by image processing with maximum Z projection. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
The negative controls are as follows :
-ve control 1 : Myelin Basic Protein (ab7349) at a 1/200 dilution, followed by Goat anti-Rabbit (Alexa Fluor® 594) (ab150080) at a 1/1000 dilution.
-ve control 2 : Anti-MAP2 (ab183830) at a 1/1000 dilution, followed by Goat anti-Rat (Alexa Fluor® 488) (ab150157) at a 1/1000 dilution.
- WB
Supplier Data
Western blot - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
The molecular weight observed was in consistency with the literature (PMID : 9299539).
Blocking buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (ab7349) at 1/5000 dilution
All lanes:
Human cerebellum tissue lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rat IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rat-igg-h-l-hrp-ab205720'>ab205720</a>) at 1/10000 dilution
Predicted band size: 33 kDa
Observed band size: 18.5 kDa
true
Exposure time: 1s
- WB
Supplier Data
Western blot - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
The molecular weight observed was in consistency with the literature (PMID : 9299539).
Blocking buffer : 5% NFDM/TBST.
Exposure time : Lane 1 : 3 seconds; Lane 2 : 1 second.
All lanes:
Western blot - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (ab7349) at 1/5000 dilution
Lane 1:
Mouse brain tissue lysate at 10 µg
Lane 2:
Rat brain tissue lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rat IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rat-igg-h-l-hrp-ab205720'>ab205720</a>) at 1/10000 dilution
Predicted band size: 33 kDa
Observed band size: 14-21.5 kDa
false
- ICC/IF
CiteAb
Immunocytochemistry/ Immunofluorescence - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
Immunocytochemistry-immunofluorescence using Anti-Myelin Basic Protein antibody [12], ab7349. Publication image from Rawji, K. S. et al., 2020, Acta Neuropathol, 32030468. Legend direct from paper.
Myelin debris activates microglia and myelin phagocytosis requires the scavenger receptor CD36. a Representative images of mouse microglia exposed to myelin debris and fluorescently conjugated latex beads (red) and stained for Iba1 (green) and MBP (red). b A greater percentage of microglia phagocytose myelin debris compared to latex beads over time. c Representative images of neonate, young adult, and aged microglia exposed to myelin debris and stained for Iba1 (green) and MBP (red). d Neonate and young microglia phagocytose myelin debris with a significantly greater efficiency than aged microglia. e Representative images of mouse microglia exposed to myelin debris and stained for CD11b (green) and iNOS (red). f Myelin debris stimulates the expression of iNOS in CD11b+ microglia. g Log2 fold change of RNA expression of pro- and anti-inflammatory genes from microglia activated with myelin debris for 2 h compared to naïve controls. h Venn diagram representation of the association of scavenger receptors in the set of differentially expressed genes (DAA) whose expression in microglia was regulated upon activation and that is affected due to aging. i, j Heat maps of expression levels of scavenger receptors (in DAA) in microglia isolated from young and aging mice and activated for 2 (i) and 12 h (j). Euclidean distance matrix was used for hierarchical clustering. Difference in expression of scavenger receptors in microglia from aged mice was compared to microglia from young mice and the estimated log2 fold change was plotted. k Representative images of mouse microglia exposed to myelin debris and treated with a CD36 receptor antagonist (sulfo-N-succinimidyl oleate, SSO) and stained for Iba1 (red) and MBP (green). l SSO reduces microglia phagocytosis of myelin debris. m Representative images of young and aged microglia exposed to myelin debris and treated with control, lipofectamine (Lipo), and overexpression of CD36 (CD36 OE) and stained for Iba1 (red) and MBP (green). n Overexpression of CD36 significantly enhances myelin phagocytosis by young and aged mouse microglia as well as human microglia. Values are represented as mean with the standard error of the mean. Results were analyzed with a two-way repeated-measures ANOVA with a Bonferroni’s post hoc test (b, d), a one-way repeated-measures ANOVA with a Dunnett’s post hoc test (f, l), a Wald test and Benjamin–Hochberg p value adjustment (g, i, j), a two-sided Chi-square test with Yates’ correction (h), and a one-way ANOVA with a Bonferroni’s post hoc test (n each cell type analyzed individually). Values are indicative of triplicate cultures. For panels a, c, e, k, m, scale bars equal 50 µm. For panels b, d, f, l, n, *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. For panels g, i, j, *p < 0.05
- ICC/IF
CiteAb
Immunocytochemistry/ Immunofluorescence - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
Immunocytochemistry-immunofluorescence using Anti-Myelin Basic Protein antibody [12], ab7349. Publication image from Rawji, K. S. et al., 2020, Acta Neuropathol, 32030468. Legend direct from paper.
Myelin debris activates microglia and myelin phagocytosis requires the scavenger receptor CD36. a Representative images of mouse microglia exposed to myelin debris and fluorescently conjugated latex beads (red) and stained for Iba1 (green) and MBP (red). b A greater percentage of microglia phagocytose myelin debris compared to latex beads over time. c Representative images of neonate, young adult, and aged microglia exposed to myelin debris and stained for Iba1 (green) and MBP (red). d Neonate and young microglia phagocytose myelin debris with a significantly greater efficiency than aged microglia. e Representative images of mouse microglia exposed to myelin debris and stained for CD11b (green) and iNOS (red). f Myelin debris stimulates the expression of iNOS in CD11b+ microglia. g Log2 fold change of RNA expression of pro- and anti-inflammatory genes from microglia activated with myelin debris for 2 h compared to naïve controls. h Venn diagram representation of the association of scavenger receptors in the set of differentially expressed genes (DAA) whose expression in microglia was regulated upon activation and that is affected due to aging. i, j Heat maps of expression levels of scavenger receptors (in DAA) in microglia isolated from young and aging mice and activated for 2 (i) and 12 h (j). Euclidean distance matrix was used for hierarchical clustering. Difference in expression of scavenger receptors in microglia from aged mice was compared to microglia from young mice and the estimated log2 fold change was plotted. k Representative images of mouse microglia exposed to myelin debris and treated with a CD36 receptor antagonist (sulfo-N-succinimidyl oleate, SSO) and stained for Iba1 (red) and MBP (green). l SSO reduces microglia phagocytosis of myelin debris. m Representative images of young and aged microglia exposed to myelin debris and treated with control, lipofectamine (Lipo), and overexpression of CD36 (CD36 OE) and stained for Iba1 (red) and MBP (green). n Overexpression of CD36 significantly enhances myelin phagocytosis by young and aged mouse microglia as well as human microglia. Values are represented as mean with the standard error of the mean. Results were analyzed with a two-way repeated-measures ANOVA with a Bonferroni’s post hoc test (b, d), a one-way repeated-measures ANOVA with a Dunnett’s post hoc test (f, l), a Wald test and Benjamin–Hochberg p value adjustment (g, i, j), a two-sided Chi-square test with Yates’ correction (h), and a one-way ANOVA with a Bonferroni’s post hoc test (n each cell type analyzed individually). Values are indicative of triplicate cultures. For panels a, c, e, k, m, scale bars equal 50 µm. For panels b, d, f, l, n, *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. For panels g, i, j, *p < 0.05
- IF
CiteAb
Immunofluorescence - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
Immunofluorescence using Anti-Myelin Basic Protein antibody [12], ab7349. Publication image from Zaremba, A. et al., 2015, Nat Commun, 25766071. Legend direct from paper.
Guanabenz decreases IFN-γ-induced hypomyelination in rat cerebellar slice cultures.(a–e) Anti-MBP staining of myelinated fibres (a, arrowheads) in slice cultures that were (a) untreated, (b) treated with IFN-γ or (c–e) concomitantly treated with IFN-γ and 2.5, 5.0 or 10.0 µM guanabenz. Images representative of two or three slices per treatment; the experiment was performed twice. (f) Electron microscopy analysis of slice cultures. Note the significant increase in the number of myelinated axons (arrowheads) when guanabenz and IFN-γ were concomitantly added to slices. Myelinated axons per field were determined by analysis of a minimum of 200 axons per condition. (g) Toluidine blue staining of slices left untreated, treated with IFN-γ alone or treated with IFN-γ and guanabenz. Images represent a minimum of three sections per treatment. Unpaired t-test, *P<0.05. Data are presented as mean±s.e.m. Scale bars, 100 µm (a–e), 2 µm (f) and 20 µm (g). WM : white matter, GL : granule cell layer, PCL : Purkinje cell layer.
- IHC
CiteAb
Immunohistochemistry - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
Immunohistochemistry using Anti-Myelin Basic Protein antibody [12], ab7349. Publication image from Romero-Ramirez, L. et al., 2020, J Biomed Sci, 32066435. Legend direct from paper.
The presence of non-phosphorylated filaments as an indicator of axonal damage. Ten weeks after SCI immune staining with Smi32 antibody (red) was combined with myelin basic protein-IR (green) and Hoechst-33342 nuclear staining (blue). a-f Overview of transverse spinal cord sections at intervals of approximately 3.2 mm from 8 mm anterior to 8 mm posterior of the lesion site; 5x objective, scale bar in a. Note the presence of Smi32-binding in the ascending dorsal columns anterior but not posterior of the lesion site and in white matter tracts in all sections. g Non-phosphorylated neurofilament in ascending fiber tracts anterior of the site of injury, 20x objective. h-i Higher magnification of Smi32-IR in white matter (h) and motor neurons in the ventral horn (i), 40x objective, scale bar in i. No Smi32 staining was observed in the white matter of animals without SCI (see Fig. 8)
- WB
CiteAb
Western blot - Anti-Myelin Basic Protein antibody [12] - Oligodendrocyte Marker (AB7349)
Western Blotting using Anti-Myelin Basic Protein antibody [12], ab7349. Publication image from Monk, K. R. et al., 2015, Nat Commun, 25607655. Legend direct from paper.
Loss of GPR56 causes CNS hypomyelination in mice.(a) Reduced FluoroMyelin staining was observed in the CC of P14 and P28 brains of Gpr56−/− mice (lower panel) compared with their littermate control (upper panel). Scale bar, 500 µm. (b) Bar graphs depicted percentage of area myelinated. Myelin is reduced at P14 (*P=0.0144; unpaired t-test, n=4 per genotype) and P28 (*P=0.0499; unpaired t-test, n=3 per genotype) in the CC of Gpr56−/− compared with controls. (c) Western blot analyses of MBP and PLP expression in the CC of Gpr56+/− and Gpr56−/− mice at P7-28. Loading control : β-actin. (d,e) Bar graphs depicted relative optical density of MBP and PLP to the loading control β-actin. MBP protein was significantly reduced in the CC of Gpr56−/− compared with Gpr56+/− littermates on P14 (*P=0.0285), P21 (*P=0.0315) and P28 (*P=0.0443). Unpaired t-test, n=3 per genotype. PLP protein was significantly decreased in the CC of Gpr56−/− compared with Gpr56+/− littermates on P7 (**P=0.0091), P14 (***P<0.0001), P21 (**P=0.0011) and P28 (**P=0.003). Unpaired t-test, n=4 per genotype. Error bars are means ± s.e.m.
false
Related conjugates and formulations (1)
-
Anti-Myelin Basic Protein antibody [12] - BSA and Azide free
Reactivity data
Product details
Anti-Myelin Basic Protein antibody [12] (ab7349) is a rat recombinant monoclonal antibody and is validated for use in ICC/IF, IHC-P and WB.
Anti-Myelin Basic Protein antibody [12] (ab7349) was first used in a scientific publication in 1987 and has been cited over 310 times in peer reviewed journals. It's performance in Western blot, immunofluorescence and IHC in mouse samples is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-Myelin Basic Protein antibody [12] (ab7349) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-Myelin Basic Protein antibody [12] (ab7349) has 22 independent reviews from customers.
Anti-Myelin Basic Protein antibody [12] (ab7349) specifically detects Myelin Basic Protein (UniProt ID: P02686; Molecular weight: 34kDa) and is sold in 100 ug and 1 mg selling sizes.
Conjugation-ready, carrier free format available for antibody clone 12 - ab277483.
Myelin Basic Protein (MBP) is a critical protein in neuro research, particularly for its role in the formation and maintenance of the myelin sheath. This sheath insulates nerve fibers, significantly increasing the speed of electrical signal transmission. Researchers use MBP to study myelination processes and demyelinating diseases such as multiple sclerosis, making it essential for understanding nerve function and pathology in various neurological conditions. Its expression helps in assessing the integrity and repair of myelin in the central nervous system.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MBP is not just a passive structural element; it binds and interacts with lipids and other proteins to maintain the compact structure of the myelin sheath. MBP forms part of a complex that includes various other proteins and lipids ensuring the stability and function of myelin. Misfolding or altered expression of MBP can compromise myelin integrity affecting the insulation of neural pathways and signal transmission.
Pathways
MBP is an essential component in the pathways of myelination and neural plasticity. It plays a role in the signaling pathways that stimulate the development and maintenance of the myelin sheath. The protein interacts with other elements of the myelin sheath such as proteolipid protein (PLP) and myelin-associated glycoprotein (MAG) to coordinate its formation and repair processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (430)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:691 PubMed41053007
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica communications 13:205 PubMed41024271
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature metabolism 7:2099-2116 PubMed40987840
2025
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 31:e70565 PubMed40931631
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature 646:1232-1242 PubMed40931074
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 135: PubMed40875460
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature neuroscience 28:1868-1882 PubMed40796665
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica communications 13:171 PubMed40796891
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:29053 PubMed40781105
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 19:1622874 PubMed40766184
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com